Hyaluronic Acid
A naturally occurring substance found in connective tissue, skin, and joint fluid throughout the body. It holds moisture, lubricates joints, and adds volume to skin. Used in many forms: injectable fillers for facial volume, joint injections for arthritis, topical serums for skin hydration, and oral supplements. Different sizes (molecular weights) have different effects. People use it for wrinkles, joint pain, and skin hydration.
Dosage
Intra-articular: 20-60 mg per injection. Topical: 0.1-2% serum. Oral: 120-240 mg daily
Dosages shown are for research reference only. Always consult a qualified healthcare provider.
Half-Life
Intra-articular: 24-72 hours (1-3 days) | Dermal filler: 4320-12960 hours (6-18 months) depending on cross-linking
Half-Life Calculator →
Shop Research-Grade Peptides
99%+ purity · US-based · third-party lab tested
Getting Started — Here's What You'll Need
Effects
Joint Lubrication
Restores synovial fluid viscosity and shock-absorbing properties in arthritic joints.
Skin Hydration
Each molecule binds up to 1,000x its weight in water for dermal volume and hydration.
Wound Healing
CD44 receptor signaling stimulates fibroblast collagen synthesis.
Mechanism of Action
Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, linked by alternating beta-1,4 and beta-1,3 glycosidic bonds. Its extraordinary water-binding capacity — a single HA molecule can bind up to 1,000 times its weight in water — is due to the highly hydrophilic carboxyl groups on the glucuronic acid residues, which create a massive hydration shell around the polymer chain.
In joints, high-molecular-weight HA (>1 million Daltons) is the primary determinant of synovial fluid viscosity and elasticity (viscoelasticity). Healthy synovial fluid contains 2-4 mg/mL of HA at molecular weights of 6-7 million Daltons, creating a non-Newtonian fluid that becomes more viscous under slow shear (cushioning at rest) and more elastic under rapid shear (shock absorption during movement). Viscosupplementation with injected HA restores these rheological properties in osteoarthritic joints where endogenous HA has degraded. Beyond simple lubrication, injected HA also reduces inflammatory mediators by binding to CD44 and RHAMM receptors on synovial cells, suppressing IL-1β and TNF-α production.
In skin, HA occupies the extracellular matrix of the dermis, providing volume, hydration, and structural support. It signals through the CD44 receptor (the primary HA receptor) on dermal fibroblasts, activating downstream pathways that stimulate collagen synthesis, fibroblast proliferation, and tissue remodeling. Different molecular weights of HA have different biological effects: high-molecular-weight HA (>500 kDa) is anti-inflammatory and provides structural volume; low-molecular-weight HA fragments (oligosaccharides) are pro-angiogenic and stimulate immune responses, which is useful for wound healing but must be considered in dermal filler applications. Cross-linked HA (used in dermal fillers like Juvederm and Restylane) is chemically modified with BDDE or other cross-linkers to resist enzymatic degradation by hyaluronidases, extending residence time from days to 6-18 months.
Regulatory Status
FDA approved for multiple indications. Dermal fillers (Juvederm, Restylane). Viscosupplementation (Synvisc, Hyalgan). Topical/oral as cosmetics/supplements.
Risks & Safety
Common
swelling, bruising, pain at injection site, temporary joint stiffness with joint injections.
Serious
if accidentally injected into a blood vessel, can block blood flow and cause tissue death or blindness around the eyes; lump formation, infection.
Rare
severe allergic reaction, delayed allergic reactions, bluish discoloration under the skin.
Compare Hyaluronic Acid With
Research Papers
30Published: February 10, 2026
AI Summary
Antibiotics loaded into hyaluronic acid hydrogels did not harm bone cells at clinical doses and effectively inhibited Staphylococcus aureus. Cefuroxime was released faster than vancomycin, suggesting the hydrogel could be used to treat implant-related infections in orthopedics.
Published: February 9, 2026
AI Summary
Peptide–drug conjugates with gold nanoparticles in a hyaluronic acid hydrogel achieved strong tumor suppression in breast cancer when combined with heat and chemotherapy. The system released drug in response to tumor acidity and could be activated with light for localized treatment.
Published: February 24, 2026
AI Summary
Collagen scaffolds with heparin promoted muscle cell growth and differentiation better than those with hyaluronic acid or chondroitin sulfate. Heparin also trapped more IGF-1, a key growth factor, highlighting how scaffold chemistry can be tuned for muscle tissue engineering.
Published: February 5, 2026
AI Summary
Patients with obstructive jaundice had higher blood levels of shed glycocalyx components—hyaluronic acid, chondroitin sulfate, and syndecan-1—and increased vascular permeability. Protecting the glycocalyx may offer a way to improve outcomes around surgery in these patients.
Published: February 5, 2026
AI Summary
Manganese oxide nanoparticles coated with hyaluronic acid and the mitochondria-targeting peptide SS31 reduced kidney damage and improved survival in mice with ischemia-reperfusion injury. Delivering antioxidants to mitochondria may help break the cycle of oxidative stress and inflammation in acute kidney injury.
Published: February 4, 2026
AI Summary
The 7S domain of type IV collagen was evaluated as a noninvasive marker for portal hypertension and high-risk varices in liver disease. The work aims to identify a reliable blood test alternative to invasive pressure measurement.
Published: February 2, 2026
AI Summary
A hyaluronic acid–cinnamic acid conjugate improved diarrhea, gut sensitivity, and barrier function in a mouse model of IBS-D by modulating serotonin signaling and gut bacteria. The compound delivered more cinnamic acid to the colon than free cinnamic acid alone, suggesting a potential new treatment for IBS-D.
Published: February 1, 2026
AI Summary
Nanoparticles carrying a peptide that blocks CD154–CD11b binding, when combined with CTLA-4Ig, prolonged skin graft survival in mice and reduced donor-reactive T cells. Some mice treated for 100 days developed lasting tolerance without further immunosuppression.
Published: February 3, 2026
AI Summary
Soluble antigen arrays built on hyaluronic acid and displaying type 1 diabetes autoantigens engaged human T cell clones with high specificity. The platform could support targeted immunotherapy for type 1 diabetes without broad immunosuppression.
Published: March 13, 2026
AI Summary
IL-10 was encapsulated in peptide nanocrystals and released slowly over about a month, protecting the cytokine from degradation. When embedded in gelatin–hyaluronic acid or PHBV matrices, the system reduced inflammation in cell culture and could support treatment of inflammatory skin conditions.
Published: April 4, 2026
AI Summary
A carbon monoxide–releasing platform using hyaluronic acid to target microglia reduced inflammation, eased hypoxia, and protected neurons in a spinal cord injury model. The system releases CO in response to reactive oxygen species, offering a potential therapy for neurotrauma.
Published: January 29, 2026
AI Summary
A poly-lysine and hyaluronic acid coating on implant materials killed bacteria on contact and reduced bacterial adhesion by up to 5 logs without harming bone cells. The coating could help prevent prosthetic joint infections without relying on antibiotics.
Published: May 13, 2026
AI Summary
Liraglutide loaded into silica nanoparticles coated with a cell-penetrating peptide and hyaluronic acid was absorbed orally in diabetic rats, lowering blood sugar and body weight comparably to injected liraglutide. The approach could enable non-injectable delivery of peptide drugs.
Published: January 27, 2026
AI Summary
Medical fabric coated with polyarginine and hyaluronic acid reduced bacterial load by at least 6 logs and prevented biofilm formation in wound infection models, including MRSA. The antibiotic-free coating could help prevent wound infections and combat resistant bacteria.
Published: January 5, 2026
AI Summary
Hydrogels combining peptide gelators with graphene oxide functionalized with hyaluronic acid enabled controlled release of HA for osteoarthritis treatment. The nanocomposites aim to support cartilage repair and reduce inflammation while mimicking the mechanical environment of joint tissue.
Published: January 5, 2026
AI Summary
Different molecular weights of hyaluronan had distinct effects in a rat model of acute respiratory distress syndrome, with mixed-weight HA providing the best improvement in lung structure and function. The results suggest HA-based strategies could be tailored for ARDS treatment.
Published: January 26, 2026
AI Summary
Serum soluble ASGR1 was higher in patients with fatty liver disease and linked to adiponectin. The work explores whether this receptor could serve as a biomarker or target in metabolic liver disease.
Published: February 19, 2026
AI Summary
A hyaluronic acid–glucose hydrogel that releases glucose when enzymes cleave it helped stem cells survive and function in low-glucose conditions. The stem cell secretome from this hydrogel improved chondrocyte growth and reduced inflammation, suggesting a potential treatment for osteoarthritis.
Published: February 20, 2026
AI Summary
Hyaluronic acid–coated nanoparticles carrying doxorubicin delivered drug selectively to tumor cells, where glutathione triggered release and fluorescence. In mice, the system reduced tumor volume fivefold compared to saline and twofold compared to free drug, with minimal toxicity.
Published: February 1, 2026
AI Summary
A modified proinsulin antigen on a hyaluronic acid backbone targeted anti-insulin B cells without affecting blood sugar. The approach could support antigen-specific immunotherapy for type 1 diabetes while avoiding hormonal side effects.
Published: February 3, 2026
AI Summary
An injectable hydrogel that crosslinks with calcium in the joint reduced inflammation, scavenged reactive oxygen species, and improved arthritis scores in rats, outperforming dexamethasone. The natural components—hyaluronic acid, alginate, and paeoniflorin—support its potential for clinical use in rheumatoid arthritis.
Published: February 16, 2026
AI Summary
Exosomes engineered to target cartilage and loaded into hyaluronic acid microspheres promoted cartilage repair and slowed osteoarthritis progression in mice. The system retained exosomes in the joint longer and improved cartilage scores, suggesting a promising strategy for OA treatment.
Published: February 1, 2026
AI Summary
Antibodies fused to an hyaluronic acid–binding domain stayed in the brain longer after injection into the ventricles, improving exposure compared to unmodified antibodies. The approach could help develop more effective antibody therapies for brain and spinal cord disorders.
Published: December 29, 2025
AI Summary
Dissolvable microneedles made from hyaluronic acid and polyvinyl alcohol delivered capsaicin-loaded nanomicelles through the skin, reducing fat mass and promoting fat browning in obese mice. The protocol offers a minimally invasive way to deliver hydrophobic compounds for obesity management.
Published: January 15, 2026
AI Summary
Coating mesenchymal stem cells with a hyaluronic acid–based matrix that mimics fibrotic tissue boosted their ability to break down collagen and reduce scarring in a heart attack model. The approach could improve cell-based therapies for fibrotic diseases.
Published: January 17, 2026
AI Summary
Gynostemma pentaphyllum extract and its bioactive compound Damulin B reduced UV-induced wrinkles, preserved collagen and hyaluronic acid, and improved skin hydration in mice. The effects were linked to lower oxidative stress and restored signaling pathways that maintain skin structure.
Published: February 12, 2026
AI Summary
A gelatin–hyaluronic acid hydrogel loaded with polydopamine-coated cerium dioxide killed bacteria under near-infrared light and shifted macrophages toward a healing phenotype. In infected wounds, the combined treatment achieved over 95% healing by day 15.
Published: January 14, 2026
AI Summary
Egyptian experts reached consensus on which dermocosmetic ingredients to use in common skin scenarios for Fitzpatrick skin types III–V. The recommendations provide guidance for populations often underrepresented in existing guidelines.
Published: January 13, 2026
AI Summary
Crocin reduced liver fibrosis in rats by targeting inflammatory and fibrotic pathways, including NF-kappaB and TGF-beta. The work explores whether this plant compound could support recovery from liver scarring.
Published: February 11, 2026
AI Summary
FGF23 bound to hyaluronic acid, chitosan, and other charged polymers with different strengths, and desorbed more easily from negatively charged surfaces. The findings inform design of carriers and materials for FGF23-related therapies.
Frequently Asked Questions
What is Hyaluronic Acid?
A naturally occurring substance found in connective tissue, skin, and joint fluid throughout the body. It holds moisture, lubricates joints, and adds volume to skin. Used in many forms: injectable fillers for facial volume, joint injections for arthritis, topical serums for skin hydration, and oral supplements. Different sizes (molecular weights) have different effects. People use it for wrinkles, joint pain, and skin hydration.
What is Hyaluronic Acid used for?
A naturally occurring substance found in connective tissue, skin, and joint fluid throughout the body. It holds moisture, lubricates joints, and adds volume to skin. Used in many forms: injectable fillers for facial volume, joint injections for arthritis, topical serums for skin hydration, and oral supplements. Different sizes (molecular weights) have different effects. People use it for wrinkles, joint pain, and skin hydration.
What is the dosage for Hyaluronic Acid?
Intra-articular: 20-60 mg per injection, series of 3-5 weekly injections. Dermal filler: varies by area and product, administered by trained practitioners. Topical: 0.1-2% serums once or twice daily. Oral: 120-240 mg once daily.
What are the side effects of Hyaluronic Acid?
Common: swelling, bruising, pain at injection site, temporary joint stiffness with joint injections. Serious: if accidentally injected into a blood vessel, can block blood flow and cause tissue death or blindness around the eyes; lump formation, infection. Rare: severe allergic reaction, delayed allergic reactions, bluish discoloration under the skin.
How does Hyaluronic Acid work?
Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, linked by alternating beta-1,4 and beta-1,3 glycosidic bonds. Its extraordinary water-binding capacity — a single HA molecule can bind up to 1,000 times its weight in water — is due to the highly hydrophilic carboxyl groups on the glucuronic acid residues, which create a massive hydration shell around the polymer chain. In joints, high-molecular-weight HA (>1 million Daltons) is the primary determinant of synovial fluid viscosity and elasticity (viscoelasticity). Healthy synovial fluid contains 2-4 mg/mL of HA at molecular weights of 6-7 million Daltons, creating a non-Newtonian fluid that becomes more viscous under slow shear (cushioning at rest) and more elastic under rapid shear (shock absorption during movement). Viscosupplementation with injected HA restores these rheological properties in osteoarthritic joints where endogenous HA has degraded. Beyond simple lubrication, injected HA also reduces inflammatory mediators by binding to CD44 and RHAMM receptors on synovial cells, suppressing IL-1β and TNF-α production. In skin, HA occupies the extracellular matrix of the dermis, providing volume, hydration, and structural support. It signals through the CD44 receptor (the primary HA receptor) on dermal fibroblasts, activating downstream pathways that stimulate collagen synthesis, fibroblast proliferation, and tissue remodeling. Different molecular weights of HA have different biological effects: high-molecular-weight HA (>500 kDa) is anti-inflammatory and provides structural volume; low-molecular-weight HA fragments (oligosaccharides) are pro-angiogenic and stimulate immune responses, which is useful for wound healing but must be considered in dermal filler applications. Cross-linked HA (used in dermal fillers like Juvederm and Restylane) is chemically modified with BDDE or other cross-linkers to resist enzymatic degradation by hyaluronidases, extending residence time from days to 6-18 months.
How is Hyaluronic Acid administered?
Hyaluronic Acid is administered via intra-articular injection, dermal injection, topical, or oral.
What is the half-life of Hyaluronic Acid?
The half-life of Hyaluronic Acid is Intra-articular: 24-72 hours (1-3 days) | Dermal filler: 4320-12960 hours (6-18 months) depending on cross-linking.
Is Hyaluronic Acid legal?
FDA approved for multiple indications. Dermal fillers (Juvederm, Restylane). Viscosupplementation (Synvisc, Hyalgan). Topical/oral as cosmetics/supplements.
Related Peptides
Ara-290
A peptide derived from EPO (the hormone that boosts red blood cells) but engineered to keep only the tissue-protective effects — it doesn't increase red blood cells at all. It activates the body's repair receptors to protect tissues and regenerate nerves. Particularly promising for nerve damage and tissue injury from poor blood flow. People use it for diabetic nerve damage and similar conditions.
Botulinum Toxin
A toxin produced by bacteria — the most potent biological toxin known, yet one of the most widely used cosmetic and medical treatments globally. In carefully controlled doses, it temporarily relaxes targeted muscles by blocking the signal that tells muscles to contract. Approved for cosmetic wrinkle reduction and many medical conditions including chronic migraine, excessive sweating, and neck muscle spasms. People use it for forehead lines, crow's feet, frown lines, and various medical conditions.
BPC-157
A healing compound made from a protein found in stomach fluid. It's the most studied peptide for tissue repair, with research showing it helps heal tendons, ligaments, muscles, the gut, and other organs. It's stable enough to survive stomach acid, so you can take it either by injection under the skin or by mouth.
BPC-157 + TB-500
A two-in-one product that pairs BPC-157 and TB-500 to target different healing pathways. BPC-157 focuses on gut, tendon, and ligament repair by supporting blood vessel growth and nitric oxide signaling, while TB-500 helps cells move to injury sites for body-wide tissue repair. The most popular peptide combination for healing and recovery.